Migraine is a neurological disorder that affects millions of children and adolescents worldwide. Chronic migraine is a subtype of migraine in which patients experience headaches for more days than not each month, with accompanying symptoms of phonophobia, photophobia, nausea or vomiting for most of these headaches. The burden and impact of chronic migraine in the daily lives of children and adolescents is substantial, requiring a holistic, multidisciplinary, and biopsychosocial approach to conceptualiza-tion and treatment. The purpose of this review is to provide a comprehensive "2022" overview of acute and preventive treatments for the management of chronic migraine in youth. We first describe diagnostic criteria for chronic migraine and highlight the state of evidence for acute and preventive treatment in children and adolescents. We then discuss emerging treatments currently receiving rigorous clinical research effort, special considerations for the treatment of chronic migraine in children and adolescents, and avenues for improving existing treatments and expanding access to evidence-based care.
CITATION STYLE
Gibler, R. C., Knestrick, K. E., Reidy, B. L., Lax, D. N., & Powers, S. W. (2022). Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? Pediatric Health, Medicine and Therapeutics, Volume 13, 309–323. https://doi.org/10.2147/phmt.s334744
Mendeley helps you to discover research relevant for your work.